ANIDO ARMANDO (Chairman & Chief Exec. Officer) received a stock award from ZYNERBA PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/2/2023ACC: 0000899243-23-003732
DirectorOfficer· Chairman & Chief Exec. Officer
Since Aug 2018
+30.71K
Net shares
Net buyer
$7.0K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
42.44K acquired · 11.73K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+42.44K
Price / share
—
Trade value
—
% of position
5.1%
1/31/2023
826.24K→868.67K
Common Stock
Direct
Shares
−11.73K
Price / share
$0.60
Trade value
$6.98K
% of position
1.3%
2/1/2023
868.67K→856.95K
Total
Net shares
+30.71K
Net value
-$6.98K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2023 | A · Award | +42.44K | — | — | 5.1% | 826.24K | 868.67K |
| Common Stock Direct | 2/1/2023 | F · Tax Withholding | −11.73K | $0.60 | $6.98K | 1.3% | 868.67K | 856.95K |
| Total | +30.71K | -$6.98K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned13.30K
Common Stock
IndirectShares owned26.59K
Total
39.89K indirect39.89K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 13.30K | Indirect |
| Common Stock | 26.59K | Indirect |
| Total | 39.89K | 39.89K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported